Chronic pain syndrome exacerbation refers to an acute worsening of pain in a patient with established chronic pain (≥3 months), driven by a complex interplay of biological, psychological, and social factors. [1] The primary clinical challenge is ruling out new or dangerous pathology while providing effective multimodal analgesia and avoiding harm from opioid escalation. [1-2]
1. History
- Pain characterization: Onset of exacerbation, location (same vs. new), quality (nociceptive vs. neuropathic vs. nociplastic), severity (NRS), radiation, and comparison to baseline pain [1][3]
- Triggers: Recent physical activity change, injury, psychosocial stressor, sleep disruption, weather change, medication non-adherence, or recent procedure [1][3]
- Progression: Gradual vs. sudden worsening; constant vs. intermittent; functional impact (ADLs, work, mobility) [3]
- Associated symptoms: Fatigue, sleep disturbance, cognitive difficulties ("brain fog"), mood changes, numbness/tingling, weakness [3-4]
- Important negatives: Fever, weight loss, bowel/bladder dysfunction, saddle anesthesia, progressive neurologic deficits, new trauma [5-6]
- Current pain regimen: All medications (prescribed and OTC), doses, adherence, recent changes, and perceived effectiveness [1]
2. Alarm Features
- New neurologic deficits: Progressive weakness, sensory loss, gait instability → concern for cord compression, cauda equina syndrome [5-6]
- Bowel/bladder dysfunction or saddle anesthesia → cauda equina syndrome (prevalence ~0.04% in LBP) [5]
- Fever + pain → spinal epidural abscess, osteomyelitis, septic arthritis (especially with IV drug use, indwelling catheters, immunosuppression) [5][7]
- Unintentional weight loss + history of cancer → metastatic disease (LR+ 27.9 when combined with clinical suspicion) [5]
- Trauma with neurologic findings → vertebral fracture (LR+ 31.1) [5]
- Vascular symptoms: Pulsatile abdominal mass, tearing pain → aortic pathology
- Suicidal ideation: Chronic pain is associated with higher suicide rates; screen at every exacerbation visit [1]
3. Medications
Acute exacerbation management (ED/urgent care)
- NSAIDs (ibuprofen 400–600 mg PO, ketorolac 15–30 mg IV): First-line for nociceptive/inflammatory flares [2][8]
- Acetaminophen 1000 mg PO/IV: Adjunct; oral preferred unless NPO [8]
- Subdissociative ketamine (0.25–0.5 mg/kg IV over 15–20 min): Effective for acute exacerbations of chronic pain (80–83% achieved ≥20 mm VAS reduction vs. 41% placebo); does not provide sustained relief beyond 24–48 hours [8-9]
- IV lidocaine: May benefit renal colic, acute radicular pain, post-herpetic neuralgia; avoid in structural heart disease or rhythm disturbances [8]
- Regional anesthesia/nerve blocks: Consider for anatomically localizable pain [8]
Chronic management (by pain type)
- Nociceptive pain: Topical NSAIDs (diclofenac gel), oral NSAIDs (lowest dose, shortest duration), duloxetine [10-11]
- Neuropathic pain: Gabapentin/pregabalin (NNT 2.9–7.7), duloxetine (NNT 6.4), TCAs (NNT 3.6; avoid in elderly), topical lidocaine, high-concentration capsaicin [1][11]
- Nociplastic/fibromyalgia: Pregabalin, duloxetine, milnacipran; NSAIDs have small effects; avoid opioids (less effective, carry serious risks) [3][10]
Medications to avoid or use with caution
- Meperidine: Avoid (neurotoxic metabolite normeperidine) [12]
- Skeletal muscle relaxants: No benefit for chronic pain; avoid in elderly [12-13]
- Benzodiazepines: No benefit for chronic pain; significant harm risk [13]
- Gabapentinoid + opioid + benzodiazepine combinations: Avoid per AGS Beers Criteria [12]
- Methadone: QTc prolongation risk; requires ECG monitoring [14-15]
4. Diet
- Anti-inflammatory diet: Emphasize fruits, vegetables, whole grains, omega-3 fatty acids; reduce processed foods and refined sugars [3]
- Weight management: Weight loss improves pain and function in osteoarthritis and low back pain; a key self-management strategy [1][11]
- Hydration: Adequate hydration supports medication metabolism and reduces constipation (common with opioids)
- Caffeine/alcohol: Excessive use can worsen sleep quality and pain sensitization; alcohol interacts with analgesics
5. Review of Systems
- Musculoskeletal: Joint swelling, stiffness, range of motion limitations, new deformity
- Neurologic: Numbness, tingling, weakness, gait changes, radicular symptoms
- Psychiatric: Depression (PHQ-2/9), anxiety (GAD-7), sleep quality, suicidal ideation [1][3]
- GI: Constipation (opioid-related), nausea, GI bleeding symptoms (NSAID use)
- Constitutional: Fever, night sweats, weight loss (red flags for malignancy/infection) [6]
- Genitourinary: Urinary retention or incontinence (cauda equina) [5]
- Other somatic symptoms: Sensitivity to light, noise, temperature (suggestive of central sensitization) [4]
6. Collateral History and Family History
- Collateral: Confirm medication use, functional status changes, behavioral observations from family/caregivers; verify controlled substance use via PDMP [11]
- Family history: Chronic pain conditions, fibromyalgia, autoimmune disease, mood disorders, substance use disorders [3]
- Social context: Employment status, disability claims, litigation (yellow flags), social support, housing stability, history of trauma/abuse [1][13][16]
- Childhood adversity: Early-life adverse experiences predispose to chronic pain development [3][17]
7. Risk Factors
- Biological: Female sex, older age, genetics (heritability 21–67% for back pain), obesity, smoking (OR 1.24), prior pain history, sleep disorders [1][16][18]
- Psychological: Depression, anxiety, PTSD, catastrophizing, fear-avoidance behavior (LR+ 2.11), poor coping skills [1][16][18]
- Social: Low socioeconomic status (OR 2.0), poor social support (OR 1.21), low educational attainment, sedentary lifestyle, occupational hazards, hostile work environment [16][18]
- Iatrogenic: Opioid-induced hyperalgesia, medication overuse, deconditioning from prolonged inactivity [1]
- Flare-specific triggers: Psychosocial stressors, sleep disruption, weather changes, overexertion, medication non-adherence, infections [3-4]
8. Differential Diagnosis
The critical task during an exacerbation is distinguishing a flare of known chronic pain from new pathology:
- New fracture (vertebral compression, pathologic): Especially with osteoporosis, steroid use, trauma, malignancy [5-6]
- Infection: Epidural abscess, discitis, osteomyelitis, septic arthritis (IV drug use, immunosuppression, recent procedure) [5]
- Malignancy: Primary or metastatic (history of cancer + clinical suspicion: LR+ 27.9) [5]
- Cauda equina syndrome: Urinary retention, saddle anesthesia, bilateral leg weakness [5]
- Referred visceral pain: Aortic aneurysm, pancreatitis, nephrolithiasis, endocarditis [5]
- Inflammatory arthritis: New-onset RA, crystal arthropathy, PMR [19]
- Neuropathy progression: Diabetic neuropathy, B12 deficiency, thyroid disease [20]
- Central sensitization/nociplastic pain: Pain disproportionate to structural pathology, widespread distribution, associated fatigue/cognitive symptoms [3-4]
- Medication-related: Opioid-induced hyperalgesia, NSAID rebound, medication withdrawal [1]
- Psychiatric exacerbation: Depression, anxiety, somatization amplifying pain perception [1][21]
9. Past Medical History
- Prior chronic pain diagnoses, duration, and trajectory
- Previous surgeries (especially spine, joint replacements)
- History of substance use disorder (opioids, alcohol, benzodiazepines)
- Mental health diagnoses (depression, anxiety, PTSD, personality disorders)
- Comorbidities affecting medication choice: CKD, liver disease, GI bleeding, cardiovascular disease [11]
- Prior interventional procedures (injections, nerve blocks, spinal cord stimulator)
- Previous ED visits for pain exacerbations (pattern recognition)
10. Physical Exam
- Vitals: Tachycardia, hypertension (pain-related), fever (infection), hypotension (sepsis, medication effect)
- General: Affect, pain behaviors, functional assessment (gait, transfers)
- Musculoskeletal: Focal tenderness, range of motion, joint swelling/effusion, deformity, trigger points
- Neurologic (critical):
- Motor strength (graded), sensation (dermatomal), deep tendon reflexes
- Straight leg raise (sensitivity 92% for herniated disc) and crossed SLR (specificity 90%) [22]
- Saddle sensation, rectal tone (if cauda equina suspected)
- Gait assessment
- Skin: Injection sites, signs of IV drug use, skin breakdown, rashes (herpes zoster)
- Abdominal: Pulsatile mass (AAA), CVA tenderness (renal pathology)
- Signs of central sensitization: Allodynia (pain with light touch), hyperalgesia, widespread non-dermatomal pain distribution [4]
11. Lab Studies
Labs are not routinely indicated for a straightforward chronic pain flare without red flags. Order selectively based on clinical suspicion: [3]
- CBC, CRP, ESR: If infection, malignancy, or inflammatory condition suspected [7]
- BMP/CMP: Baseline renal/hepatic function before NSAID or acetaminophen use; electrolytes if on methadone (hypokalemia/hypomagnesemia increase QTc risk) [14]
- Urine drug screen: If opioid therapy is being managed or substance use disorder is suspected; verify PDMP [11]
- TSH, vitamin D, B12: If hypothyroidism, osteomalacia, or neuropathy suspected [19-20]
- HbA1c: If diabetic neuropathy progression suspected
- Creatine kinase: If myopathy suspected (statin-related, inflammatory) [19]
- Blood cultures: If fever + concern for epidural abscess or endocarditis [5]
12. Imaging
- Routine imaging is NOT recommended for chronic pain exacerbations without red flags or new neurologic findings [13]
- When to image:
- Red flag symptoms (see above)
- New or progressive neurologic deficit
- Pain not responding to ≥6 weeks of conservative therapy
- Pre-procedural planning (injection, surgery)
- First-line: MRI of the affected region (spine, joint) — best for soft tissue, disc, cord, infection, tumor [13][22]
- CT: If MRI contraindicated; better for bony detail (fractures)
- X-ray: Limited utility; may show fractures, alignment, spondylolisthesis
- Important caveat: Imaging findings (disc bulges, degenerative changes) are common in asymptomatic individuals and may not correlate with the pain complaint [22]
The following figure from the AAFP illustrates a stepwise approach to chronic low back pain management, including when imaging is appropriate:
13. Special Tests
- PDMP (Prescription Drug Monitoring Program): Check at every visit involving controlled substances [11]
- Screening tools:
- PHQ-9 for depression
- GAD-7 for anxiety
- PEG scale (Pain, Enjoyment, General activity) for functional assessment
- Opioid Risk Tool (ORT) or SOAPP-R for opioid misuse risk
- STarT Back Tool: Predicts progression from acute to chronic pain [13]
- Central Sensitization Inventory: Screens for nociplastic pain features [4]
- Point-of-care ultrasound: Joint effusion assessment, nerve block guidance
- EMG/NCS: If neuropathy or radiculopathy needs characterization (outpatient)
14. ECG
- Not routinely indicated for all chronic pain patients
- Obtain ECG if:
- Patient is on methadone (baseline, within 30 days, annually, and at doses >30–40 mg/day or >100 mg/day) [14]
- Patient is on TCAs (amitriptyline, nortriptyline) — QTc prolongation risk [23]
- Patient is on buprenorphine at higher doses with CYP3A4 inhibitors [15]
- Syncope, palpitations, or new arrhythmia symptoms
- Multiple QT-prolonging medications [15]
- Dangerous patterns: QTc >500 ms on methadone → discontinue or switch opioid; QTc 450–500 ms → consider alternative [14]
- Bradycardia: Can occur with opioid use; evaluate if symptomatic [24]
15. Assessment
Chronic pain syndrome exacerbation is a biopsychosocial phenomenon requiring classification of the pain type (nociceptive, neuropathic, or nociplastic) to guide treatment. [1] Chronic pain affects ~20% of US adults and is a leading cause of disability. [10] Flares are often multifactorial, driven by physical deconditioning, psychosocial stressors, sleep disruption, and medication issues rather than new structural pathology. [1][4]
Severity stratification
- Mild flare: Increased pain with preserved function → outpatient management
- Moderate flare: Significant functional decline, medication failure → urgent care/ED evaluation, medication adjustment
- Severe flare: Intractable pain, red flag features, suicidal ideation, or new neurologic deficits → emergent evaluation and possible admission
Complications: Opioid misuse/overdose, medication side effects (GI bleeding from NSAIDs, serotonin syndrome from SNRIs), deconditioning, depression, functional decline, chronic opioid dependence [1][11]
16. Treatment Plan
Initial stabilization (ED/acute setting)
- Multimodal analgesia: NSAID + acetaminophen as foundation [2][8]
- Subdissociative ketamine (0.25 mg/kg IV over 15–20 min) for refractory pain — comparable efficacy at low and high subdissociative doses [9][25]
- Regional anesthesia/nerve blocks when anatomically appropriate [8]
- Avoid opioid escalation as first-line; if opioids are necessary, use lowest effective dose for shortest duration [11]
- Address acute psychosocial crisis (social work, psychiatry if suicidal)
Outpatient pharmacologic management (by pain type): [10-11]
Non-pharmacologic interventions (first-line per CDC, APA, and multiple guidelines): [3][11][26]
- Exercise therapy (aerobic, aquatic, strengthening, yoga, tai chi)
- Cognitive behavioral therapy (CBT) — small but consistent benefit for pain and disability
- Mindfulness-based stress reduction (MBSR)
- Physical therapy with spinal stabilization
- Acupuncture, massage, spinal manipulation
- Multidisciplinary rehabilitation for refractory cases
- Sleep hygiene optimization, weight management, smoking cessation
17. Disposition
Discharge criteria (majority of patients)
- Red flags excluded
- Pain improved to tolerable/functional baseline
- Safe medication plan in place
- Outpatient follow-up arranged
- No suicidal ideation
Observation/admission criteria
- New neurologic deficit requiring urgent imaging/intervention
- Suspected spinal infection, epidural abscess, or malignancy
- Intractable pain despite multimodal ED management
- Suicidal ideation with plan
- Inability to perform basic ADLs or unsafe home environment
- Need for IV medication titration (e.g., ketamine infusion protocol)
Specialist consultation triggers
- Pain medicine: Refractory pain, interventional procedure candidacy, opioid management complexity
- Neurosurgery/orthopedics: Progressive neurologic deficit, cauda equina, surgical pathology
- Psychiatry: Suicidality, severe comorbid psychiatric illness, substance use disorder
- Rheumatology: Suspected inflammatory or autoimmune etiology
18. Follow Up / Return Precautions
Follow-up timing
- PCP or pain specialist within 1–2 weeks after ED visit for medication adjustment and reassessment
- Physical therapy initiation within 2–4 weeks
- Psychology/CBT referral as soon as feasible [1][26]
Return immediately for
- New weakness, numbness, or difficulty walking
- Loss of bowel or bladder control
- Fever or chills with worsening pain
- Severe uncontrolled pain despite prescribed medications
- Thoughts of self-harm
Patient counseling points
- Pain flares are expected in chronic pain — the goal is improved function, not complete pain elimination [1][3]
- Remain physically active; avoid prolonged bed rest [13]
- Engage in self-management strategies (exercise, sleep hygiene, stress reduction) [1][3]
- Avoid escalating opioids independently; contact the prescribing clinician first [11]
- Expected recovery: Most flares improve within days to weeks with multimodal management; persistent worsening warrants re-evaluation
References
1. Chronic Pain: An Update on Burden, Best Practices, and New Advances. — Cohen SP, Vase L, Hooten WM. Lancet. 2021.
2. A Review of Current and Emerging Approaches to Pain Management in the Emergency Department. — Todd KH. Pain and Therapy. 2017.
3. Nociplastic Pain: Towards an Understanding of Prevalent Pain Conditions. — Fitzcharles MA, Cohen SP, Clauw DJ, et al. Lancet. 2021.
4. Central Sensitization: When It Is Not “All in Your Head”. — Mohabbat AB, Wilkinson JM. American Family Physician. 2023.
5. Diagnosis and Treatment of Low Back Pain (LBP) (2022). — Maj Danielle Anderson DPT DSc OCS FAAOMPT, Thiru M. Annaswamy MD MA, LTC Adam J. Bevevino MD, et al Department of Veterans Affairs. 2022.
6. Acute Low Back Pain: Diagnosis and Management. — Earwood JS, Doles NA, Russell RS. American Family Physician. 2025.
7. ACR Appropriateness Criteria® Cervical Pain or Cervical Radiculopathy: 2024 Update. — Eldaya RW, Parsons MS, Hutchins TA, et al. Journal of the American College of Radiology : JACR. 2025.
8. Optimizing the Treatment of Acute Pain in the Emergency Department. — American College of Emergency Physicians (2018). 2018.
9. Subdissociative-Dose Ketamine Is Effective for Treating Acute Exacerbations of Chronic Pain. — Lumanauw DD, Youn S, Horeczko T, Yadav K, Tanen DA. Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine. 2019.
10. Nonopioid Pharmacologic Management of Chronic Noncancer Pain. — Sokol R, Grossman E, Bourgery R. American Family Physician. 2025.
11. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. — Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports. 2022.
12. Alternative Treatments to Selected Medications in the 2023 American Geriatrics Society Beers Criteria®. — Steinman MA. Journal of the American Geriatrics Society. 2025.
13. Chronic Low Back Pain in Adults: Evaluation and Management. — Maharty DC, Hines SC, Brown RB. American Family Physician. 2024.
14. Use of Opioids in the Management of Chronic Pain (2022). — Nicole Brown DPT OCS SCS FPS, Jamie Clinton-Lont MS CNP, Ellen Edens MD MPE, et al Department of Veterans Affairs. 2022.
15. Cardiovascular Complications of Opioid Use: JACC State-of-the-Art Review. — Krantz MJ, Palmer RB, Haigney MCP. Journal of the American College of Cardiology. 2021.
16. The Biopsychosocial Factors Associated With Development of Chronic Musculoskeletal Pain. An Umbrella Review and Meta-Analysis of Observational Systematic Reviews. — Dunn M, Rushton AB, Mistry J, Soundy A, Heneghan NR. PloS One. 2023.
17. The Neuroscience of Pain: Biobehavioral, Developmental, and Psychosocial Mechanisms Relevant to Intervention Targets. — Atlas LY, alʼAbsi M. Psychosomatic Medicine. 2018.
18. Low Back Pain. — Knezevic NN, Candido KD, Vlaeyen JWS, Van Zundert J, Cohen SP. Lancet. 2021.
19. Polymyalgia Rheumatica. — Dejaco C, Matteson EL. The New England Journal of Medicine. 2026.
20. Pain and the Brain: Chronic Widespread Pain. — Arnold LM. The Journal of Clinical Psychiatry. 2009.
21. Persistent Physical Symptoms: Definition, Genesis, and Management. — Löwe B, Toussaint A, Rosmalen JGM, et al. Lancet. 2024.
22. Nonspecific Low Back Pain. — Chiarotto A, Koes BW. The New England Journal of Medicine. 2022.
23. The QT Interval Prolongation Potential of Anticancer and Supportive Drugs: A Comprehensive Overview. — Giraud EL, Ferrier KRM, Lankheet NAG, et al. The Lancet. Oncology. 2022.
24. Cardiac Effects of Opioid Therapy. — Chen A, Ashburn MA. Pain Medicine. 2015.
25. Efficacy of Analgesic and Sub-Dissociative Dose Ketamine for Acute Pain in the Emergency Department. — Beaudrie-Nunn AN, Wieruszewski ED, Woods EJ, et al. The American Journal of Emergency Medicine. 2023.
26. Clinical Practice Guideline for Psychological and Other Nonpharmacological Treatment of Chronic Musculoskeletal Pain in Adults. — Ravi Prasad, Kathryn L. Mueller, Daniel Bruns, et al American Psychological Association (2024). 2024.